Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array

Wennuan Liu, Baoli Chang, Jurga Sauvageot, Latchezar Dimitrov, Marta Gielzak, Tao Li, Guifang Yan, Jishan Sun, Jielin Sun, Tamara S. Adams, Aubrey R. Turner, Jin Woo Kim, Deborah A. Meyers, Siqun Lilly Zheng, William B Isaacs, Jianfeng Xu

Research output: Contribution to journalArticle

Abstract

Although multiple recurrent chromosomal alterations have been identified in prostate cancer cells, the specific genes driving the apparent selection of these changes remain largely unknown. In part, this uncertainty is due to the limited resolution of the techniques used to detect these alterations. In this study, we applied a high-resolution genome-wide method, Affymetrix 100K SNP mapping array, to screen for somatic DNA copy number (CN) alterations among 22 pairs of samples from primary prostate cancers and matched nonmalignant tissues. We detected 355 recurrent deletions and 223 recurrent gains, many of which were novel. As expected, the sizes of novel alterations tend to be smaller. Importantly, among tumors with increasing grade, Gleason sum 6, 7, and 8, we found a significant trend of larger number of alterations in the tumors with higher grade. Overall, gains are significantly more likely to occur within genes (74%) than are deletions (49%). However, when we looked at the most frequent CN alterations, defined as those in ≥4 subjects, we observed that both gains (85%) and deletions (57%) occur preferentially within genes. An example of a novel, recurrent alteration observed in this study was a deletion between the ERG and TMPRSS2 genes on chromosome 21, presumably related to the recently identified fusion transcripts from these two genes. Results from this study provide a basis for a systematic and comprehensive cataloging of CN alterations associated with grades of prostate cancer, and the subsequent identification of specific genes that associated with initiation and progression of the disease.

Original languageEnglish (US)
Pages (from-to)1018-1032
Number of pages15
JournalGenes Chromosomes and Cancer
Volume45
Issue number11
DOIs
StatePublished - Nov 2006

Fingerprint

Single Nucleotide Polymorphism
Prostatic Neoplasms
DNA
Genes
Cataloging
Chromosomes, Human, Pair 21
Gene Deletion
Uncertainty
Disease Progression
Neoplasms
Genome

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array. / Liu, Wennuan; Chang, Baoli; Sauvageot, Jurga; Dimitrov, Latchezar; Gielzak, Marta; Li, Tao; Yan, Guifang; Sun, Jishan; Sun, Jielin; Adams, Tamara S.; Turner, Aubrey R.; Kim, Jin Woo; Meyers, Deborah A.; Zheng, Siqun Lilly; Isaacs, William B; Xu, Jianfeng.

In: Genes Chromosomes and Cancer, Vol. 45, No. 11, 11.2006, p. 1018-1032.

Research output: Contribution to journalArticle

Liu, W, Chang, B, Sauvageot, J, Dimitrov, L, Gielzak, M, Li, T, Yan, G, Sun, J, Sun, J, Adams, TS, Turner, AR, Kim, JW, Meyers, DA, Zheng, SL, Isaacs, WB & Xu, J 2006, 'Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array', Genes Chromosomes and Cancer, vol. 45, no. 11, pp. 1018-1032. https://doi.org/10.1002/gcc.20369
Liu, Wennuan ; Chang, Baoli ; Sauvageot, Jurga ; Dimitrov, Latchezar ; Gielzak, Marta ; Li, Tao ; Yan, Guifang ; Sun, Jishan ; Sun, Jielin ; Adams, Tamara S. ; Turner, Aubrey R. ; Kim, Jin Woo ; Meyers, Deborah A. ; Zheng, Siqun Lilly ; Isaacs, William B ; Xu, Jianfeng. / Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array. In: Genes Chromosomes and Cancer. 2006 ; Vol. 45, No. 11. pp. 1018-1032.
@article{9519acf77c1a48859521f42dd29b878d,
title = "Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array",
abstract = "Although multiple recurrent chromosomal alterations have been identified in prostate cancer cells, the specific genes driving the apparent selection of these changes remain largely unknown. In part, this uncertainty is due to the limited resolution of the techniques used to detect these alterations. In this study, we applied a high-resolution genome-wide method, Affymetrix 100K SNP mapping array, to screen for somatic DNA copy number (CN) alterations among 22 pairs of samples from primary prostate cancers and matched nonmalignant tissues. We detected 355 recurrent deletions and 223 recurrent gains, many of which were novel. As expected, the sizes of novel alterations tend to be smaller. Importantly, among tumors with increasing grade, Gleason sum 6, 7, and 8, we found a significant trend of larger number of alterations in the tumors with higher grade. Overall, gains are significantly more likely to occur within genes (74{\%}) than are deletions (49{\%}). However, when we looked at the most frequent CN alterations, defined as those in ≥4 subjects, we observed that both gains (85{\%}) and deletions (57{\%}) occur preferentially within genes. An example of a novel, recurrent alteration observed in this study was a deletion between the ERG and TMPRSS2 genes on chromosome 21, presumably related to the recently identified fusion transcripts from these two genes. Results from this study provide a basis for a systematic and comprehensive cataloging of CN alterations associated with grades of prostate cancer, and the subsequent identification of specific genes that associated with initiation and progression of the disease.",
author = "Wennuan Liu and Baoli Chang and Jurga Sauvageot and Latchezar Dimitrov and Marta Gielzak and Tao Li and Guifang Yan and Jishan Sun and Jielin Sun and Adams, {Tamara S.} and Turner, {Aubrey R.} and Kim, {Jin Woo} and Meyers, {Deborah A.} and Zheng, {Siqun Lilly} and Isaacs, {William B} and Jianfeng Xu",
year = "2006",
month = "11",
doi = "10.1002/gcc.20369",
language = "English (US)",
volume = "45",
pages = "1018--1032",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array

AU - Liu, Wennuan

AU - Chang, Baoli

AU - Sauvageot, Jurga

AU - Dimitrov, Latchezar

AU - Gielzak, Marta

AU - Li, Tao

AU - Yan, Guifang

AU - Sun, Jishan

AU - Sun, Jielin

AU - Adams, Tamara S.

AU - Turner, Aubrey R.

AU - Kim, Jin Woo

AU - Meyers, Deborah A.

AU - Zheng, Siqun Lilly

AU - Isaacs, William B

AU - Xu, Jianfeng

PY - 2006/11

Y1 - 2006/11

N2 - Although multiple recurrent chromosomal alterations have been identified in prostate cancer cells, the specific genes driving the apparent selection of these changes remain largely unknown. In part, this uncertainty is due to the limited resolution of the techniques used to detect these alterations. In this study, we applied a high-resolution genome-wide method, Affymetrix 100K SNP mapping array, to screen for somatic DNA copy number (CN) alterations among 22 pairs of samples from primary prostate cancers and matched nonmalignant tissues. We detected 355 recurrent deletions and 223 recurrent gains, many of which were novel. As expected, the sizes of novel alterations tend to be smaller. Importantly, among tumors with increasing grade, Gleason sum 6, 7, and 8, we found a significant trend of larger number of alterations in the tumors with higher grade. Overall, gains are significantly more likely to occur within genes (74%) than are deletions (49%). However, when we looked at the most frequent CN alterations, defined as those in ≥4 subjects, we observed that both gains (85%) and deletions (57%) occur preferentially within genes. An example of a novel, recurrent alteration observed in this study was a deletion between the ERG and TMPRSS2 genes on chromosome 21, presumably related to the recently identified fusion transcripts from these two genes. Results from this study provide a basis for a systematic and comprehensive cataloging of CN alterations associated with grades of prostate cancer, and the subsequent identification of specific genes that associated with initiation and progression of the disease.

AB - Although multiple recurrent chromosomal alterations have been identified in prostate cancer cells, the specific genes driving the apparent selection of these changes remain largely unknown. In part, this uncertainty is due to the limited resolution of the techniques used to detect these alterations. In this study, we applied a high-resolution genome-wide method, Affymetrix 100K SNP mapping array, to screen for somatic DNA copy number (CN) alterations among 22 pairs of samples from primary prostate cancers and matched nonmalignant tissues. We detected 355 recurrent deletions and 223 recurrent gains, many of which were novel. As expected, the sizes of novel alterations tend to be smaller. Importantly, among tumors with increasing grade, Gleason sum 6, 7, and 8, we found a significant trend of larger number of alterations in the tumors with higher grade. Overall, gains are significantly more likely to occur within genes (74%) than are deletions (49%). However, when we looked at the most frequent CN alterations, defined as those in ≥4 subjects, we observed that both gains (85%) and deletions (57%) occur preferentially within genes. An example of a novel, recurrent alteration observed in this study was a deletion between the ERG and TMPRSS2 genes on chromosome 21, presumably related to the recently identified fusion transcripts from these two genes. Results from this study provide a basis for a systematic and comprehensive cataloging of CN alterations associated with grades of prostate cancer, and the subsequent identification of specific genes that associated with initiation and progression of the disease.

UR - http://www.scopus.com/inward/record.url?scp=33748924290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748924290&partnerID=8YFLogxK

U2 - 10.1002/gcc.20369

DO - 10.1002/gcc.20369

M3 - Article

VL - 45

SP - 1018

EP - 1032

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 11

ER -